The company’s compliance to SOC 2 Type II demonstrates the suitability of the design and operating effectiveness of its controls relevant to security TORONTO, Dec. 12, 2023 /PRNewswire/ — MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.